Sarepta Therapeutics Inc
XMUN:AB3A
Sarepta Therapeutics Inc
XMUN:AB3A
Price:
15.3
EUR
4.22%
Market Closed
Market Cap:
€950.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
|
S
|
Schroders PLC
F:PYX
|
UK |
|
M
|
Microsoft Corp
DUS:MSF
|
US |
Shareholder Yield
Current shareholder yield for 
AB3A is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
AB3A Price
Sarepta Therapeutics Inc
Sarepta Therapeutics Inc
Annual Price Range
15.3
52w Low
10.24
52w High
20.9
Price Metrics
| Average Annual Return | 21.34% |
| Standard Deviation of Annual Returns | 35.66% |
| Max Drawdown | -93% |
Shares Statistics
| Market Capitalization | 1.9B EUR |
| Shares Outstanding | 62 096 878 |
| Percentage of Shares Shorted |
N/A
|
AB3A Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
AB3A's latest stock split occurred on Jul 12, 2012
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
The adjusted shares began trading on Jul 12, 2012. This was the only stock split in AB3A's history.
Pre-Split Price
N/A
Post-Split Price
19.795
Before
After
